NEW YORK, June 30 (Reuters) - Pfizer Inc said on Monday that U.S. health regulators approved its long-acting pet antibiotic, Convenia, to treat most common skin infections in dogs and cats.
NEW YORK, June 30 (Reuters) - Pfizer Inc said on Monday that U.S. health regulators approved its long-acting pet antibiotic, Convenia, to treat most common skin infections in dogs and cats.